Cargando…
Docosahexaenoic Acid Supplementation in Lactating Women Increases Breast Milk and Erythrocyte Membrane Docosahexaenoic Acid Concentrations and Alters Infant n–6:n–3 Fatty Acid Ratio
BACKGROUND: Low concentrations of docosahexaenoic acid (DHA) or high n–6 (ω-6):n–3 ratio in pregnant women is associated with poor fetal growth velocity and suboptimal neurodevelopment. However, there is a lack of data on levels of important n–6 and n–3 fatty acids (FAs) at different time points dur...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Nutrition
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10590723/ https://www.ncbi.nlm.nih.gov/pubmed/37877035 http://dx.doi.org/10.1016/j.cdnut.2023.102010 |
_version_ | 1785124053424537600 |
---|---|
author | Khandelwal, Shweta Kondal, Dimple Gupta, Ruby Chaudhry, Monica Dutta, Soumam Ramakrishnan, Lakshmy Patil, Kamal Swamy, M.K. Prabhakaran, Dorairaj Tandon, Nikhil Ramakrishnan, Usha Stein, Aryeh D. |
author_facet | Khandelwal, Shweta Kondal, Dimple Gupta, Ruby Chaudhry, Monica Dutta, Soumam Ramakrishnan, Lakshmy Patil, Kamal Swamy, M.K. Prabhakaran, Dorairaj Tandon, Nikhil Ramakrishnan, Usha Stein, Aryeh D. |
author_sort | Khandelwal, Shweta |
collection | PubMed |
description | BACKGROUND: Low concentrations of docosahexaenoic acid (DHA) or high n–6 (ω-6):n–3 ratio in pregnant women is associated with poor fetal growth velocity and suboptimal neurodevelopment. However, there is a lack of data on levels of important n–6 and n–3 fatty acids (FAs) at different time points during pregnancy and lactation from India. Data on how much DHA is transferred during actual supplementation are also scarce. OBJECTIVES: We report the concentrations of n–6 and n–3 FAs in maternal and infant blood and in breast milk following maternal supplementation with DHA or placebo. METHODS: A total of 957 pregnant women (≤20 wk) from Belagavi, Karnataka, were randomly assigned to receive either 400 mg/d of algal DHA or placebo through 6 mo postpartum. Blood samples were collected from the mother at recruitment/baseline, delivery, and 6 mo postpartum and from the infant at birth (cord) and 12 mo (venous). Breast milk samples were collected from a subsample at delivery, 1 mo and 6 mo postpartum. The FA profile was analyzed using gas chromatography. RESULTS: The concentration of DHA appeared to be higher in erythrocyte and breast milk samples of the DHA-supplemented group at all subsequent time points. The n–6:n–3 ratio was lower among women in the DHA group at delivery [DHA: 4.08 (1.79); placebo: 5.84 (3.57); P < 0.001] and at 6 mo postpartum [DHA: 5.34 (2.64); placebo: 7.69 (2.9); P < 0.001]. Infants of DHA-supplemented mothers also had a lower n–6:n–3 ratio at delivery and 12 mo. The n–6:n–3 ratio of breast milk increased from delivery through 1 to 6 mo but remained lower in the DHA-supplemented group than in the placebo. CONCLUSIONS: Maternal DHA supplementation with 400 mg/d from early pregnancy through 6 mo postpartum significantly increased circulating DHA in breast milk and infant erythrocyte, whereas decreased erythrocyte and breast milk n–6:n–3 ratio. However, maternal supplementation did not get the ratio to the recommended levels. |
format | Online Article Text |
id | pubmed-10590723 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Society for Nutrition |
record_format | MEDLINE/PubMed |
spelling | pubmed-105907232023-10-24 Docosahexaenoic Acid Supplementation in Lactating Women Increases Breast Milk and Erythrocyte Membrane Docosahexaenoic Acid Concentrations and Alters Infant n–6:n–3 Fatty Acid Ratio Khandelwal, Shweta Kondal, Dimple Gupta, Ruby Chaudhry, Monica Dutta, Soumam Ramakrishnan, Lakshmy Patil, Kamal Swamy, M.K. Prabhakaran, Dorairaj Tandon, Nikhil Ramakrishnan, Usha Stein, Aryeh D. Curr Dev Nutr Original Research BACKGROUND: Low concentrations of docosahexaenoic acid (DHA) or high n–6 (ω-6):n–3 ratio in pregnant women is associated with poor fetal growth velocity and suboptimal neurodevelopment. However, there is a lack of data on levels of important n–6 and n–3 fatty acids (FAs) at different time points during pregnancy and lactation from India. Data on how much DHA is transferred during actual supplementation are also scarce. OBJECTIVES: We report the concentrations of n–6 and n–3 FAs in maternal and infant blood and in breast milk following maternal supplementation with DHA or placebo. METHODS: A total of 957 pregnant women (≤20 wk) from Belagavi, Karnataka, were randomly assigned to receive either 400 mg/d of algal DHA or placebo through 6 mo postpartum. Blood samples were collected from the mother at recruitment/baseline, delivery, and 6 mo postpartum and from the infant at birth (cord) and 12 mo (venous). Breast milk samples were collected from a subsample at delivery, 1 mo and 6 mo postpartum. The FA profile was analyzed using gas chromatography. RESULTS: The concentration of DHA appeared to be higher in erythrocyte and breast milk samples of the DHA-supplemented group at all subsequent time points. The n–6:n–3 ratio was lower among women in the DHA group at delivery [DHA: 4.08 (1.79); placebo: 5.84 (3.57); P < 0.001] and at 6 mo postpartum [DHA: 5.34 (2.64); placebo: 7.69 (2.9); P < 0.001]. Infants of DHA-supplemented mothers also had a lower n–6:n–3 ratio at delivery and 12 mo. The n–6:n–3 ratio of breast milk increased from delivery through 1 to 6 mo but remained lower in the DHA-supplemented group than in the placebo. CONCLUSIONS: Maternal DHA supplementation with 400 mg/d from early pregnancy through 6 mo postpartum significantly increased circulating DHA in breast milk and infant erythrocyte, whereas decreased erythrocyte and breast milk n–6:n–3 ratio. However, maternal supplementation did not get the ratio to the recommended levels. American Society for Nutrition 2023-09-29 /pmc/articles/PMC10590723/ /pubmed/37877035 http://dx.doi.org/10.1016/j.cdnut.2023.102010 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Original Research Khandelwal, Shweta Kondal, Dimple Gupta, Ruby Chaudhry, Monica Dutta, Soumam Ramakrishnan, Lakshmy Patil, Kamal Swamy, M.K. Prabhakaran, Dorairaj Tandon, Nikhil Ramakrishnan, Usha Stein, Aryeh D. Docosahexaenoic Acid Supplementation in Lactating Women Increases Breast Milk and Erythrocyte Membrane Docosahexaenoic Acid Concentrations and Alters Infant n–6:n–3 Fatty Acid Ratio |
title | Docosahexaenoic Acid Supplementation in Lactating Women Increases Breast Milk and Erythrocyte Membrane Docosahexaenoic Acid Concentrations and Alters Infant n–6:n–3 Fatty Acid Ratio |
title_full | Docosahexaenoic Acid Supplementation in Lactating Women Increases Breast Milk and Erythrocyte Membrane Docosahexaenoic Acid Concentrations and Alters Infant n–6:n–3 Fatty Acid Ratio |
title_fullStr | Docosahexaenoic Acid Supplementation in Lactating Women Increases Breast Milk and Erythrocyte Membrane Docosahexaenoic Acid Concentrations and Alters Infant n–6:n–3 Fatty Acid Ratio |
title_full_unstemmed | Docosahexaenoic Acid Supplementation in Lactating Women Increases Breast Milk and Erythrocyte Membrane Docosahexaenoic Acid Concentrations and Alters Infant n–6:n–3 Fatty Acid Ratio |
title_short | Docosahexaenoic Acid Supplementation in Lactating Women Increases Breast Milk and Erythrocyte Membrane Docosahexaenoic Acid Concentrations and Alters Infant n–6:n–3 Fatty Acid Ratio |
title_sort | docosahexaenoic acid supplementation in lactating women increases breast milk and erythrocyte membrane docosahexaenoic acid concentrations and alters infant n–6:n–3 fatty acid ratio |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10590723/ https://www.ncbi.nlm.nih.gov/pubmed/37877035 http://dx.doi.org/10.1016/j.cdnut.2023.102010 |
work_keys_str_mv | AT khandelwalshweta docosahexaenoicacidsupplementationinlactatingwomenincreasesbreastmilkanderythrocytemembranedocosahexaenoicacidconcentrationsandaltersinfantn6n3fattyacidratio AT kondaldimple docosahexaenoicacidsupplementationinlactatingwomenincreasesbreastmilkanderythrocytemembranedocosahexaenoicacidconcentrationsandaltersinfantn6n3fattyacidratio AT guptaruby docosahexaenoicacidsupplementationinlactatingwomenincreasesbreastmilkanderythrocytemembranedocosahexaenoicacidconcentrationsandaltersinfantn6n3fattyacidratio AT chaudhrymonica docosahexaenoicacidsupplementationinlactatingwomenincreasesbreastmilkanderythrocytemembranedocosahexaenoicacidconcentrationsandaltersinfantn6n3fattyacidratio AT duttasoumam docosahexaenoicacidsupplementationinlactatingwomenincreasesbreastmilkanderythrocytemembranedocosahexaenoicacidconcentrationsandaltersinfantn6n3fattyacidratio AT ramakrishnanlakshmy docosahexaenoicacidsupplementationinlactatingwomenincreasesbreastmilkanderythrocytemembranedocosahexaenoicacidconcentrationsandaltersinfantn6n3fattyacidratio AT patilkamal docosahexaenoicacidsupplementationinlactatingwomenincreasesbreastmilkanderythrocytemembranedocosahexaenoicacidconcentrationsandaltersinfantn6n3fattyacidratio AT swamymk docosahexaenoicacidsupplementationinlactatingwomenincreasesbreastmilkanderythrocytemembranedocosahexaenoicacidconcentrationsandaltersinfantn6n3fattyacidratio AT prabhakarandorairaj docosahexaenoicacidsupplementationinlactatingwomenincreasesbreastmilkanderythrocytemembranedocosahexaenoicacidconcentrationsandaltersinfantn6n3fattyacidratio AT tandonnikhil docosahexaenoicacidsupplementationinlactatingwomenincreasesbreastmilkanderythrocytemembranedocosahexaenoicacidconcentrationsandaltersinfantn6n3fattyacidratio AT ramakrishnanusha docosahexaenoicacidsupplementationinlactatingwomenincreasesbreastmilkanderythrocytemembranedocosahexaenoicacidconcentrationsandaltersinfantn6n3fattyacidratio AT steinaryehd docosahexaenoicacidsupplementationinlactatingwomenincreasesbreastmilkanderythrocytemembranedocosahexaenoicacidconcentrationsandaltersinfantn6n3fattyacidratio |